Loading clinical trials...
Loading clinical trials...
A Pilot Study of INCB039110 (Itacitinib) for the Treatment of Steroid Refractory Chronic Graft-Versus-Host Disease
Conditions
Interventions
Itacitinib
Locations
5
United States
Colorado Blood Cancer Institute
Denver, Colorado, United States
The Sarah Cannon Research Institute
Nashville, Tennessee, United States
South Austin Medical Center
Austin, Texas, United States
Texas Oncology - Sammons Cancer Center
Dallas, Texas, United States
Texas Transplant Institute
San Antonio, Texas, United States
Start Date
June 5, 2020
Primary Completion Date
September 7, 2023
Completion Date
September 7, 2023
Last Updated
November 6, 2024
NCT07124078
NCT05305989
NCT03640481
NCT05121142
NCT03689894
NCT05348096
Lead Sponsor
SCRI Development Innovations, LLC
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions